Pharmacotherapeutic Category: Synthetic anticholinergics, quaternary ammonium compounds.
Pharmacology: Pharmacodynamics: Otilonium bromide is endowed with a marked spasmolytic action on the smooth muscle of the digestive tract.
Pharmacokinetics: Experimental data have shown that following oral administration, absorption is extremely low and most of the absorbed quota is eliminated via the biliary tract.
Treatment of irritable bowel syndrome and painful spastic states of distal enteric tract.
One tablet 2-3 times a day.
In the animal, otilonium bromide has shown to be virtually devoid of toxicity. Accordingly, no particular problems should arise in the human in relation to recommended. In case of overdose, a possible symptomatic and support therapy is recommended.
Hypersensitivity to otilonium bromide or any of the excipients of Spasmomen.
Patients with glaucoma, prostatic hypertrophy, pyloric stenosis.
Spasmomen contains lactose and is therefore not suitable for subjects with lactase deficiency, galactosemia or glucose-galactose malabsorption syndrome.
Effects on the Ability to Drive or Operate Machinery: No effects on the capacity to drive vehicles and use machines are known to date.
Use in pregnancy & lactation: Although no embryotoxic, teratogenic or mutagenic effects on animals have been reported, as with all medicinal products, its use during pregnancy and lactation should be limited to specific cases of need and under direct medical supervision.
Although no embryotoxic, teratogenic or mutagenic effects on animals have been reported, as with all medicinal products, its use during pregnancy and lactation should be limited to specific cases of need and under direct medical supervision.
At therapeutic doses, Spasmomen does not cause adverse effects; namely it does not cause atropine-like effects.
Store at temperatures not exceeding 30°C.
A03AB06 - otilonium bromide ; Belongs to the class of synthetic anticholinergics, quaternary ammonium compounds. Used in the treatment of functional bowel disorders.
Spasmomen FC tab 40 mg
30's (P24.5/film-coated tab)